ATN posted Q4 FY2025 revenue of USD 184.2 million (+2%) and operating income of USD 15.7 million. Net loss attributable to stockholders was USD 3.3 million (USD 0.32 per share) and Adjusted EBITDA was USD 50.0 million (+8%). For FY2025, revenue was USD 728.0 million, operating income was USD 28.4 million, net loss attributable to stockholders was USD 14.9 million (USD 1.38 per share), and Adjusted EBITDA was USD 190.0 million (+3%). Net cash provided by operating activities was USD 133.9 million (+5%), capital expenditures were USD 90.0 million (net of reimbursable expenditures), and the Net Debt Ratio was 2.36x at December 31, 2025. Operationally, Q4 high-speed broadband homes passed rose 27% to 523,500 and high-speed broadband subscribers increased 3% to 145,000, while international mobile subscribers increased 3% to 399,200 and blended churn was 2.97%. ATN said a major fixed wireless deployment in Alaska expanded high-speed broadband homes passed and highlighted cost containment efforts. The company also reiterated its pending sale of about 214 tower sites in the southwest US for up to USD 297 million in cash consideration, with an initial closing expected in Q2 2026. For FY2026, ATN expects Adjusted EBITDA of USD 190 million to USD 200 million (excluding the pending US tower portfolio sale) and capital expenditures of USD 105 million to USD 115 million (net of reimbursable expenditures); the tower sale could reduce 2026 Adjusted EBITDA by USD 6 million to USD 8 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ATN International Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603041630PRIMZONEFULLFEED9666014) on March 04, 2026, and is solely responsible for the information contained therein.
Comments